Literature DB >> 19969331

Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.

Takuya Koie1, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Noritaka Kamimura, Chikara Ohyama.   

Abstract

OBJECTIVES: To evaluate oncological outcomes and voiding functions after orthotopic neobladder reconstruction with preservation of gynecologic organs in female bladder cancer patients.
METHODS: A total of 30 consecutive female patients who underwent radical cystectomy and U-shaped ileal neobladder (constructed using 40 cm of a double-folded ileal loop) substitution were retrospectively analyzed. Of the 30 patients, 29 had urothelial carcinoma and 1 had leiomyosarcoma. Computed tomography was performed every 6 months. Urethroscopic examination was performed at 3-month intervals during the first and second years, and at 6-month intervals thereafter. Pressure flow studies, including urethral pressure profilometry, were performed 3, 6, 9, and 12 months after surgery.
RESULTS: During a median follow-up of 35.7 months, 1 patient exhibited local recurrence and 6 patients died of bladder cancer. Maximum neobladder pressure examined 12 months after surgery improved significantly as compared with that examined after 3 months (P<.01). Maximal urethral closure pressure also improved significantly 12 months after surgery as compared with that after 3 months (P<.05). The capacity of the ileal neobladder 3 months after operation was 204+/-84 mL, and it showed a gradual increase, reaching 311+/-95 mL at 12 months (P<.01). None of the patients required catheterization for residual urine. Twenty-four patients (80%) remained completely dry day and night, voiding once or twice during the night.
CONCLUSIONS: Orthotopic neobladder reconstruction with preservation of gynecologic organs is feasible for female bladder cancer patients. Although the follow-up period was not long, the present technique provided acceptable oncological outcome and voiding function. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19969331     DOI: 10.1016/j.urology.2009.08.083

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

Review 1.  Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

Authors:  Andrea B Apolo; Vanessa Hoffman; Matthew G Kaag; David M Latini; Cheryl T Lee; Jonathan E Rosenberg; Margaret Knowles; Dan Theodorescu; Bogdan A Czerniak; Jason A Efstathiou; Matthew L Albert; Srikala S Sridhar; Vitaly Margulis; Surena F Matin; Matthew D Galsky; Donna Hansel; Ashish M Kamat; Thomas W Flaig; Angela B Smith; Edward Messing; Diane Zipursky Quale; Yair Lotan
Journal:  Urol Oncol       Date:  2014-07-25       Impact factor: 3.498

Review 2.  Management of Voiding Dysfunction After Female Neobladder Creation.

Authors:  Nathan Y Hoy; Joshua A Cohn; Casey G Kowalik; Melissa R Kaufman; W Stuart Reynolds; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

Review 3.  Sexual dysfunction after cystectomy and urinary diversion.

Authors:  Rishi A Modh; John P Mulhall; Scott M Gilbert
Journal:  Nat Rev Urol       Date:  2014-07-01       Impact factor: 14.432

4.  Gynecological organ involvement at robot-assisted radical cystectomy in females: Is anterior exenteration necessary?

Authors:  Michelle Whittum; Ahmed Aly Hussein; Youssef E Ahmed; Hijab Khan; Collin Krasowski; Neil B Huben; Paul R May; Tomoaki Terakawa; Qiang Li; Khurshid A Guru
Journal:  Can Urol Assoc J       Date:  2018-05-14       Impact factor: 1.862

5.  Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Authors:  Ayumu Kusaka; Shingo Hatakeyama; Shogo Hosogoe; Itsuto Hamano; Hiromichi Iwamura; Naoki Fujita; Ken Fukushi; Takuma Narita; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Med Oncol       Date:  2017-04-10       Impact factor: 3.064

6.  Robotic Female Radical Cystectomy.

Authors:  Hong Truong; Victoria Maxon; Alvin C Goh
Journal:  J Endourol       Date:  2021-09       Impact factor: 2.619

7.  Genital Sparing Cystectomy for Female Bladder Cancer and its Functional Outcome; a Seven Years' Experience with 24 Cases.

Authors:  Sameh Roshdy; Ahmed Senbel; Ashraf Khater; Omar Farouk; Adel Fathi; EmadEldeen Hamed; Adel Denewer
Journal:  Indian J Surg Oncol       Date:  2015-09-07

Review 8.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

9.  Survival up to 5-15 years in young women following genital sparing radical cystectomy and neobladder: oncological outcome and quality of life. Single-surgeon and single-institution experience.

Authors:  Mohamed Wishahi; Hossam Elganozoury
Journal:  Cent European J Urol       Date:  2015-01-23

10.  Simultaneous robot assisted laparoscopic radical nephroureterectomy; genital tract and paravaginal nerve sparing radical cystectomy; superextended lymph node dissection and intracorporeal Studer pouch reconstruction for bladder cancer: Robotic hat-trick.

Authors:  Erdal Alkan; Abdullah Erdem Canda; Mirac Turan; Mevlana Derya Balbay
Journal:  Cent European J Urol       Date:  2014-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.